(SON) Sonoco Products - Overview
Sector: Consumer CyclicalIndustry: Packaging & Containers | Exchange NYSE (USA) | Currency USD | Market Cap: 5.107m | Total Return 18.8% in 12m
Stock: Paperboard, Containers, Packaging, Materials, Tubes
Total Rating 58
Risk 73
Buy Signal -0.38
| Risk 5d forecast | |
|---|---|
| Volatility | 23.4% |
| Relative Tail Risk | -5.76% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.58 |
| Alpha | 9.44 |
| Character TTM | |
|---|---|
| Beta | 0.523 |
| Beta Downside | 0.838 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.46% |
| CAGR/Max DD | -0.01 |
EPS (Earnings per Share)
Revenue
Description: SON Sonoco Products March 04, 2026
Sonoco Products Company (SON) designs, manufactures, and sells engineered and sustainable packaging products globally. The company operates in two primary segments.
The Consumer Packaging segment provides rigid paper containers, steel and plastic containers, and various closures. The Industrial Paper Packaging segment focuses on paperboard tubes, cones, cores, and recycled paperboards. The packaging sector is a mature industry with established demand across various end markets.
Sonocos product offerings also include diverse packaging materials like plastic, paper, and foam. The company serves a wide range of markets, including food, textiles, and construction. Packaging companies often rely on efficient supply chains and material sourcing.
Founded in 1899, Sonoco is headquartered in Hartsville, South Carolina. Investors interested in packaging industry trends may find further analysis on ValueRay beneficial.
Headlines to watch out for
- Consumer packaging demand drives revenue growth
- Raw material cost fluctuations impact profit margins
- Industrial paper packaging sales sensitive to manufacturing output
- Regulatory changes in packaging sustainability pose compliance risks
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 1.02b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 0.00 > 1.0 |
| NWC/Revenue: 1.56% < 20% (prev -17.28%; Δ 18.84% < -1%) |
| CFO/TA 0.06 > 3% & CFO 689.8m > Net Income 1.02b |
| Net Debt (4.47b) to EBITDA (1.52b): 2.94 < 3 |
| Current Ratio: 1.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (99.7m) vs 12m ago 0.44% < -2% |
| Gross Margin: 20.94% > 18% (prev 0.22%; Δ 2.07k% > 0.5%) |
| Asset Turnover: 63.53% > 50% (prev 39.79%; Δ 23.74% > 0%) |
| Interest Coverage Ratio: 4.29 > 6 (EBITDA TTM 1.52b / Interest Expense TTM 233.5m) |
Altman Z'' 2.10
| A: 0.01 (Total Current Assets 2.65b - Total Current Liabilities 2.53b) / Total Assets 11.16b |
| B: 0.30 (Retained Earnings 3.38b / Total Assets 11.16b) |
| C: 0.08 (EBIT TTM 1.00b / Avg Total Assets 11.84b) |
| D: 0.45 (Book Value of Equity 3.42b / Total Liabilities 7.53b) |
| Altman-Z'' Score: 2.10 = BBB |
Beneish M -2.93
| DSRI: 0.62 (Receivables 1.02b/1.08b, Revenue 7.52b/4.98b) |
| GMI: 1.03 (GM 20.94% / 21.56%) |
| AQI: 0.96 (AQ_t 0.48 / AQ_t-1 0.50) |
| SGI: 1.51 (Revenue 7.52b / 4.98b) |
| TATA: 0.03 (NI 1.02b - CFO 689.8m) / TA 11.16b) |
| Beneish M-Score: -2.93 (Cap -4..+1) = A |
What is the price of SON shares?
As of March 29, 2026, the stock is trading at USD 53.19 with a total of 654,119 shares traded.
Over the past week, the price has changed by +4.97%, over one month by -5.81%, over three months by +22.13% and over the past year by +18.79%.
Over the past week, the price has changed by +4.97%, over one month by -5.81%, over three months by +22.13% and over the past year by +18.79%.
Is SON a buy, sell or hold?
Sonoco Products has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy SON.
- StrongBuy: 5
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the SON price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 64.4 | 21% |
| Analysts Target Price | 64.4 | 21% |
SON Fundamental Data Overview March 25, 2026
P/E Trailing = 8.7319
P/E Forward = 9.9305
P/S = 0.6793
P/B = 1.3829
P/EG = 0.2085
Revenue TTM = 7.52b USD
EBIT TTM = 1.00b USD
EBITDA TTM = 1.52b USD
Long Term Debt = 3.79b USD (from longTermDebt, last quarter)
Short Term Debt = 538.0m USD (from shortTermDebt, last quarter)
Debt = 4.85b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.47b USD (from netDebt column, last quarter)
Enterprise Value = 9.58b USD (5.11b + Debt 4.85b - CCE 378.4m)
Interest Coverage Ratio = 4.29 (Ebit TTM 1.00b / Interest Expense TTM 233.5m)
EV/FCF = 24.36x (Enterprise Value 9.58b / FCF TTM 393.3m)
FCF Yield = 4.10% (FCF TTM 393.3m / Enterprise Value 9.58b)
FCF Margin = 5.23% (FCF TTM 393.3m / Revenue TTM 7.52b)
Net Margin = 13.59% (Net Income TTM 1.02b / Revenue TTM 7.52b)
Gross Margin = 20.94% ((Revenue TTM 7.52b - Cost of Revenue TTM 5.94b) / Revenue TTM)
Gross Margin QoQ = 19.63% (prev 21.93%)
Tobins Q-Ratio = 0.86 (Enterprise Value 9.58b / Total Assets 11.16b)
Interest Expense / Debt = 1.07% (Interest Expense 51.8m / Debt 4.85b)
Taxrate = 24.77% (115.2m / 465.2m)
NOPAT = 753.0m (EBIT 1.00b * (1 - 24.77%))
Current Ratio = 1.05 (Total Current Assets 2.65b / Total Current Liabilities 2.53b)
Debt / Equity = 1.34 (Debt 4.85b / totalStockholderEquity, last quarter 3.61b)
Debt / EBITDA = 2.94 (Net Debt 4.47b / EBITDA 1.52b)
Debt / FCF = 11.38 (Net Debt 4.47b / FCF TTM 393.3m)
Total Stockholder Equity = 3.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.64% (Net Income 1.02b / Total Assets 11.16b)
RoE = 32.44% (Net Income TTM 1.02b / Total Stockholder Equity 3.15b)
RoCE = 14.42% (EBIT 1.00b / Capital Employed (Equity 3.15b + L.T.Debt 3.79b))
RoIC = 8.70% (NOPAT 753.0m / Invested Capital 8.66b)
WACC = 4.40% (E(5.11b)/V(9.96b) * Re(7.82%) + D(4.85b)/V(9.96b) * Rd(1.07%) * (1-Tc(0.25)))
Discount Rate = 7.82% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 0.28%
[DCF] Terminal Value 85.54% ; FCFF base≈412.2m ; Y1≈381.8m ; Y5≈347.4m
[DCF] Fair Price = 60.28 (EV 10.42b - Net Debt 4.47b = Equity 5.95b / Shares 98.6m; r=6.0% [WACC]; 5y FCF grow -9.33% → 3.0% )
EPS Correlation: -36.78 | EPS CAGR: -14.02% | SUE: 0.56 | # QB: 0
Revenue Correlation: -17.18 | Revenue CAGR: -0.04% | SUE: -0.17 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.57 | Chg7d=+0.001 | Chg30d=+0.004 | Revisions Net=-4 | Analysts=9
EPS current Year (2026-12-31): EPS=5.96 | Chg7d=-0.010 | Chg30d=-0.002 | Revisions Net=+0 | Growth EPS=+4.3% | Growth Revenue=-0.9%
EPS next Year (2027-12-31): EPS=6.55 | Chg7d=-0.019 | Chg30d=+0.033 | Revisions Net=+3 | Growth EPS=+10.0% | Growth Revenue=+1.8%
[Analyst] Revisions Ratio: -0.67 (1 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -3.5% (Discount Rate 7.9% - Earnings Yield 11.5%)
[Growth] Growth Spread = +1.9% (Analyst -1.6% - Implied -3.5%)
P/E Forward = 9.9305
P/S = 0.6793
P/B = 1.3829
P/EG = 0.2085
Revenue TTM = 7.52b USD
EBIT TTM = 1.00b USD
EBITDA TTM = 1.52b USD
Long Term Debt = 3.79b USD (from longTermDebt, last quarter)
Short Term Debt = 538.0m USD (from shortTermDebt, last quarter)
Debt = 4.85b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.47b USD (from netDebt column, last quarter)
Enterprise Value = 9.58b USD (5.11b + Debt 4.85b - CCE 378.4m)
Interest Coverage Ratio = 4.29 (Ebit TTM 1.00b / Interest Expense TTM 233.5m)
EV/FCF = 24.36x (Enterprise Value 9.58b / FCF TTM 393.3m)
FCF Yield = 4.10% (FCF TTM 393.3m / Enterprise Value 9.58b)
FCF Margin = 5.23% (FCF TTM 393.3m / Revenue TTM 7.52b)
Net Margin = 13.59% (Net Income TTM 1.02b / Revenue TTM 7.52b)
Gross Margin = 20.94% ((Revenue TTM 7.52b - Cost of Revenue TTM 5.94b) / Revenue TTM)
Gross Margin QoQ = 19.63% (prev 21.93%)
Tobins Q-Ratio = 0.86 (Enterprise Value 9.58b / Total Assets 11.16b)
Interest Expense / Debt = 1.07% (Interest Expense 51.8m / Debt 4.85b)
Taxrate = 24.77% (115.2m / 465.2m)
NOPAT = 753.0m (EBIT 1.00b * (1 - 24.77%))
Current Ratio = 1.05 (Total Current Assets 2.65b / Total Current Liabilities 2.53b)
Debt / Equity = 1.34 (Debt 4.85b / totalStockholderEquity, last quarter 3.61b)
Debt / EBITDA = 2.94 (Net Debt 4.47b / EBITDA 1.52b)
Debt / FCF = 11.38 (Net Debt 4.47b / FCF TTM 393.3m)
Total Stockholder Equity = 3.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.64% (Net Income 1.02b / Total Assets 11.16b)
RoE = 32.44% (Net Income TTM 1.02b / Total Stockholder Equity 3.15b)
RoCE = 14.42% (EBIT 1.00b / Capital Employed (Equity 3.15b + L.T.Debt 3.79b))
RoIC = 8.70% (NOPAT 753.0m / Invested Capital 8.66b)
WACC = 4.40% (E(5.11b)/V(9.96b) * Re(7.82%) + D(4.85b)/V(9.96b) * Rd(1.07%) * (1-Tc(0.25)))
Discount Rate = 7.82% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 0.28%
[DCF] Terminal Value 85.54% ; FCFF base≈412.2m ; Y1≈381.8m ; Y5≈347.4m
[DCF] Fair Price = 60.28 (EV 10.42b - Net Debt 4.47b = Equity 5.95b / Shares 98.6m; r=6.0% [WACC]; 5y FCF grow -9.33% → 3.0% )
EPS Correlation: -36.78 | EPS CAGR: -14.02% | SUE: 0.56 | # QB: 0
Revenue Correlation: -17.18 | Revenue CAGR: -0.04% | SUE: -0.17 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.57 | Chg7d=+0.001 | Chg30d=+0.004 | Revisions Net=-4 | Analysts=9
EPS current Year (2026-12-31): EPS=5.96 | Chg7d=-0.010 | Chg30d=-0.002 | Revisions Net=+0 | Growth EPS=+4.3% | Growth Revenue=-0.9%
EPS next Year (2027-12-31): EPS=6.55 | Chg7d=-0.019 | Chg30d=+0.033 | Revisions Net=+3 | Growth EPS=+10.0% | Growth Revenue=+1.8%
[Analyst] Revisions Ratio: -0.67 (1 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -3.5% (Discount Rate 7.9% - Earnings Yield 11.5%)
[Growth] Growth Spread = +1.9% (Analyst -1.6% - Implied -3.5%)